General Information of This Antibody
Antibody ID
ANI0CKYEB
Antibody Name
HSL156
Synonyms
Anti-human JAM3 mouse mAb
   Click to Show/Hide
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized IgG3-kappa
Antigen Name
Junctional adhesion molecule C (JAM3)
 Antigen Info 
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
HSL156 mAb-DT3C conjugate [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 3 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
1.90 ng/mL
Positive JAM3 expression (JAM3 +++/++)
Method Description
In vitro cytotoxicity of ADCs against a panel of four multiple human small cell cancer cell lines.
In Vitro Model Lung small cell carcinoma LU-134-A cells CVCL_1387
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
15.00 ng/mL
Positive JAM3 expression (JAM3 +++/++)
Method Description
In vitro cytotoxicity of ADCs against a panel of four multiple human small cell cancer cell lines.
In Vitro Model Lung small cell carcinoma LU-135 cells CVCL_1389
Experiment 3 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
15.00 ng/mL
Positive JAM3 expression (JAM3 +++/++)
Method Description
In vitro cytotoxicity of ADCs against a panel of four multiple human small cell cancer cell lines.
In Vitro Model Lung small cell carcinoma SBC-5 cells CVCL_1679
References
Ref 1 Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma. Exp Cell Res. 2023 May 15;426(2):113570. doi: 10.1016/j.yexcr.2023.113570. Epub 2023 Mar 27.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.